Advancing lifelong precision medicine for cardiovascular diseases through gut microbiota modulation

References

• Bajaj JS, Ng SC, Schnabl B. Promises of microbiome-based therapies. Journal Of Hepatology. 2022;76(6):1379–34. doi:10.1016/j.jhep.2021.12.003.
   PubMed Web of Science ®Google Scholar
• Gill SR, Pop M, DeBoy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, Gordon JI, Relman DA, Fraser-Liggett CM, Nelson KE. Metagenomic analysis of the human distal gut microbiome. Science. 2006;312(5778):1355–1359. doi:10.1126/science.1124234.
   PubMed Web of Science ®Google Scholar
• Qian B, Zhang K, Li Y, Sun K. Update on gut microbiota in cardiovascular diseases. Front Cell Infect Microbiol. 2022;12:1059349. doi:10.3389/fcimb.2022.1059349.
   PubMed Web of Science ®Google Scholar
• Wahlstrom A, Sayin SI, Marschall HU, Backhed F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metabolism. 2016;24(1):41–50. doi:10.1016/j.cmet.2016.05.005.
   PubMed Web of Science ®Google Scholar
• Guittar J, Shade A, Litchman E. Trait-based community assembly and succession of the infant gut microbiome. Nat Commun. 2019;10(1):512. doi:10.1038/s41467-019-08377-w.
   PubMedGoogle Scholar
• Fernandez L, Langa S, Martín V, Maldonado A, Jiménez E, Martín R, Rodríguez JM. The human milk microbiota: origin and potential roles in health and disease. Pharmacological Research. 2013;69(1):1–10. doi:10.1016/j.phrs.2012.09.001.
   PubMed Web of Science ®Google Scholar
• David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505(7484):559–563. doi:10.1038/nature12820.
   PubMed Web of Science ®Google Scholar
• Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, Knight R. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A. 2010;107(26):11971–11975. doi:10.1073/pnas.1002601107.
   PubMed Web of Science ®Google Scholar
• Backhed F, Roswall J, Peng Y, Feng Q, Jia H, Kovatcheva-Datchary P, Li Y, Xia Y, Xie H, Zhong H, et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host & Microbe. 2015;17(6):852. doi:10.1016/j.chom.2015.05.012.
   PubMed Web of Science ®Google Scholar
• Reyman M, van Houten MA, van Baarle D, Bosch AATM, Man WH, Chu MLJN, Arp K, Watson RL, Sanders EAM, Fuentes S, et al. Author correction: impact of delivery mode-associated gut microbiota dynamics on health in the first year of life. Nat Commun. 2019;10(1):5352. doi:10.1038/s41467-019-13373-1.
   PubMedGoogle Scholar
• Bokulich NA, Chung J, Battaglia T, Henderson N, Jay M, Li H, Lieber AD, Wu F, Perez-Perez GI, Chen Y, et al. Antibiotics, birth mode, and diet shape microbiome maturation during early life. Sci Transl Med. 2016;8(343):343ra382. doi:10.1126/scitranslmed.aad7121.
   Web of Science ®Google Scholar
• Wexler HM. Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev. 2007;20(4):593–621. doi:10.1128/CMR.00008-07.
   PubMed Web of Science ®Google Scholar
• Le Doare K, Holder B, Bassett A, Pannaraj PS. Mother’s milk: a purposeful contribution to the development of the infant microbiota and immunity. Front Immunol. 2018;9:361. doi:10.3389/fimmu.2018.00361.
   PubMed Web of Science ®Google Scholar
• Ding T, Schloss PD. Dynamics and associations of microbial community types across the human body. Nature. 2014;509(7500):357–360. doi:10.1038/nature13178.
   PubMed Web of Science ®Google Scholar
• Torow N, Hornef MW. The neonatal window of opportunity: setting the stage for life-long host-microbial interaction and immune homeostasis. The Journal Of Immunology. 2017;198(2):557–563. doi:10.4049/jimmunol.1601253.
   PubMed Web of Science ®Google Scholar
• Le Huerou-Luron I, Blat S, Boudry G. Breast- v. formula-feeding: impacts on the digestive tract and immediate and long-term health effects. Nutr Res Rev. 2010;23(1):23–36. doi:10.1017/S0954422410000065.
   PubMed Web of Science ®Google Scholar
• Shen Z, Luo W, Tan B, Nie K, Deng M, Wu S, Xiao M, Wu X, Meng X, Tong T, et al. Roseburia intestinalis stimulates TLR5-dependent intestinal immunity against Crohn’s disease. EBioMedicine. 2022;85:104285. doi:10.1016/j.ebiom.2022.104285.
   PubMed Web of Science ®Google Scholar
• Wang Y, Mortimer EK, Katundu KGH, Kalanga N, Leong LEX, Gopalsamy GL, Christophersen CT, Richard AC, Shivasami A, Abell GCJ, et al. The capacity of the fecal microbiota from Malawian infants to ferment resistant starch. Front Microbiol. 2019;10:1459. doi:10.3389/fmicb.2019.01459.
   PubMed Web of Science ®Google Scholar
• Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, Magris M, Hidalgo G, Baldassano RN, Anokhin AP, et al. Human gut microbiome viewed across age and geography. Nature. 2012;486(7402):222–227. doi:10.1038/nature11053.
   PubMed Web of Science ®Google Scholar
• Buffie CG, Pamer EG. Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol. 2013;13(11):790–801. doi:10.1038/nri3535.
   PubMed Web of Science ®Google Scholar
• Margolis KG, Cryan JF, Mayer EA. The microbiota-gut-brain axis: from motility to mood. Gastroenterology. 2021;160(5):1486–1501. doi:10.1053/j.gastro.2020.10.066.
   PubMed Web of Science ®Google Scholar
• Schoeler M, Caesar R. Dietary lipids, gut microbiota and lipid metabolism. Rev Endocr Metab Disord. 2019;20(4):461–472. doi:10.1007/s11154-019-09512-0.
   PubMed Web of Science ®Google Scholar
• Rahman MM, Islam F, Or-Rashid MH, Mamun AA, Rahaman MS, Islam MM, Meem AFK, Sutradhar PR, Mitra S, Mimi AA, et al. The gut microbiota (microbiome) in cardiovascular disease and its therapeutic regulation. Front Cell Infect Microbiol. 2022;12:903570. doi:10.3389/fcimb.2022.903570.
   PubMed Web of Science ®Google Scholar
• Boyle CA, Cordero JF, Trevathan E. The national center on birth defects and developmental disabilities: past, present, and future. Am J Prev Med. 2012;43(6):655–658. doi:10.1016/j.amepre.2012.08.015.
   PubMed Web of Science ®Google Scholar
• Zheng Z, Yang T, Chen L, Wang L, Zhang S, Wang T, Zhao L, Ye Z, Chen L, Qin J, et al. Increased maternal body mass index is associated with congenital heart defects: an updated meta-analysis of observational studies. Int J Cardiol. 2018;273:112–120. doi:10.1016/j.ijcard.2018.09.116.
   PubMed Web of Science ®Google Scholar
• Hoang TT, Marengo LK, Mitchell LE, Canfield MA, Agopian AJ. Original findings and updated meta-analysis for the association between maternal diabetes and risk for congenital heart disease phenotypes. Am J Epidemiol. 2017;186(1):118–128. doi:10.1093/aje/kwx033.
   PubMed Web of Science ®Google Scholar
• Wang T, Chen L, Huang P, Yang T, Zhang S, Zhao L, Chen L, Ye Z, Luo L, Qin J, et al. Association of maternal gut microbiota and plasma metabolism with congenital heart disease in offspring: a multi-omic analysis. Sci Rep. 2021;11(1):5339. doi:10.1038/s41598-021-84901-7.
   PubMed Web of Science ®Google Scholar
• Kleerebezem M, Vaughan EE. Probiotic and gut lactobacilli and bifidobacteria: molecular approaches to study diversity and activity. Annu Rev Microbiol. 2009;63(1):269–290. doi:10.1146/annurev.micro.091208.073341.
   PubMedGoogle Scholar
• Ronan V, Yeasin R, Claud EC. Childhood development and the microbiome—the intestinal microbiota in maintenance of health and development of disease during childhood development. Gastroenterology. 2021;160(2):495–506. doi:10.1053/j.gastro.2020.08.065.
   PubMed Web of Science ®Google Scholar
• Huang Y, Lu W, Zeng M, Hu X, Su Z, Liu Y, Liu Z, Yuan J, Li L, Zhang X, et al. Mapping the early life gut microbiome in neonates with critical congenital heart disease: multiomics insights and implications for host metabolic and immunological health. Microbiome. 2022;10(1):245. doi:10.1186/s40168-022-01437-2.
   PubMed Web of Science ®Google Scholar
• Zhang QL, Chen X-H, Zhou S-J, Lei Y-Q, Huang J-S, Chen Q, Cao H. Relationship between disorders of the intestinal microbiota and heart failure in infants with congenital heart disease. Front Cell Infect Microbiol. 2023;13:1152349. doi:10.3389/fcimb.2023.1152349.
   PubMed Web of Science ®Google Scholar
• Polsinelli VB, Marteau L, Shah SJ. The role of splanchnic congestion and the intestinal microenvironment in the pathogenesis of advanced heart failure. Curr Opin Support Palliat Care. 2019;13(1):24–30. doi:10.1097/SPC.0000000000000414.
   PubMed Web of Science ®Google Scholar
• Stein-Thoeringer CK, Nichols KB, Lazrak A, Docampo MD, Slingerland AE, Slingerland JB, Clurman AG, Armijo G, Gomes ALC, Shono Y, et al. Lactose drives Enterococcus expansion to promote graft-versus-host disease. Science. 2019;366(6469):1143–1149. doi:10.1126/science.aax3760.
   PubMed Web of Science ®Google Scholar
• Steck N, Hoffmann M, Sava IG, Kim SC, Hahne H, Tonkonogy SL, Mair K, Krueger D, Pruteanu M, Shanahan F, et al. Enterococcus faecalis metalloprotease compromises epithelial barrier and contributes to intestinal inflammation. Gastroenterology. 2011;141(3):959–971. doi:10.1053/j.gastro.2011.05.035.
   PubMed Web of Science ®Google Scholar
• Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol. 2014;12(10):661–672. doi:10.1038/nrmicro3344.
   PubMed Web of Science ®Google Scholar
• Van Hul M, Le Roy T, Prifti E, Dao MC, Paquot A, Zucker J-D, Delzenne NM, Muccioli GG, Clément K, Cani PD, et al. From correlation to causality: the case of subdoligranulum. Gut Microbes. 2020;12(1):1–13. doi:10.1080/19490976.2020.1849998.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Tang H, Chen P, Xie H, Tao Y. Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome. Signal Transduct Target Ther. 2019;4(1):41. doi:10.1038/s41392-019-0074-5.
   PubMedGoogle Scholar
• Wilson BC, Butler ÉM, Grigg CP, Derraik JGB, Chiavaroli V, Walker N, Thampi S, Creagh C, Reynolds AJ, Vatanen T, et al. Oral administration of maternal vaginal microbes at birth to restore gut microbiome development in infants born by caesarean section: A pilot randomised placebo-controlled trial. EBioMedicine. 2021;69:103443. doi:10.1016/j.ebiom.2021.103443.
   PubMed Web of Science ®Google Scholar
• Shi B, Zhang X, Song Z, Dai Z, Luo K, Chen B, Zhou Z, Cui Y, Feng B, Zhu Z. et al. Targeting gut microbiota–derived kynurenine to predict and protect the remodeling of the pressure-overloaded young heart. Sci Adv. 2023;9(28):eadg7417. doi:10.1126/sciadv.adg7417.
   PubMed Web of Science ®Google Scholar
• Liu Y, Li H-T, Zhou S-J, Zhou H-H, Xiong Y, Yang J, Zhou Y-B, Chen D-J, Liu J-M. Effects of vaginal seeding on gut microbiota, body mass index, and allergy risks in infants born through cesarean delivery: a randomized clinical trial. Am J Obstet Gynecol MFM. 2023;5(1):100793. doi:10.1016/j.ajogmf.2022.100793.
   PubMed Web of Science ®Google Scholar
• Zhou L, Qiu W, Wang J, Zhao A, Zhou C, Sun T, Xiong Z, Cao P, Shen W, Chen J, et al. Effects of vaginal microbiota transfer on the neurodevelopment and microbiome of cesarean-born infants: a blinded randomized controlled trial. Cell Host Microbe. 2023;31(7):1232–1247 e1235. doi:10.1016/j.chom.2023.05.022.
   PubMed Web of Science ®Google Scholar
• Chichlowski M, German JB, Lebrilla CB, Mills DA. The influence of milk oligosaccharides on microbiota of infants: opportunities for formulas. Annu Rev Food Sci Technol. 2011;2(1):331–351. doi:10.1146/annurev-food-022510-133743.
   PubMedGoogle Scholar
• Martin-Pelaez S, Cano-Ibanez N, Pinto-Gallardo M, Amezcua-Prieto C. The impact of probiotics, prebiotics, and synbiotics during pregnancy or lactation on the intestinal microbiota of children born by cesarean section: a systematic review. Nutrients. 2022;14(2):341. doi:10.3390/nu14020341.
   PubMed Web of Science ®Google Scholar
• Navarro-Tapia E, Sebastiani G, Sailer S, Almeida Toledano L, Serra-Delgado M, García-Algar Ó, Andreu-Fernández V. Probiotic supplementation during the perinatal and infant period: effects on gut dysbiosis and disease. Nutrients. 2020;12(8):2243. doi:10.3390/nu12082243.
   PubMed Web of Science ®Google Scholar
• Robertson C, Savva GM, Clapuci R, Jones J, Maimouni H, Brown E, Minocha A, Hall LJ, Clarke P. Incidence of necrotising enterocolitis before and after introducing routine prophylactic lactobacillus and bifidobacterium probiotics. Arch Dis Child Fetal Neonatal Ed. 2020;105(4):380–386. doi:10.1136/archdischild-2019-317346.
   PubMed Web of Science ®Google Scholar
• Dilli D, Aydin B, Zenciroğlu A, Özyazıcı E, Beken S, Okumuş N. Treatment outcomes of infants with cyanotic congenital heart disease treated with synbiotics. Pediatrics. 2013;132(4):e932–938. doi:10.1542/peds.2013-1262.
   PubMed Web of Science ®Google Scholar
• Nemet I, Li XS, Haghikia A, Li L, Wilcox J, Romano KA, Buffa JA, Witkowski M, Demuth I, König M, et al. Atlas of gut microbe-derived products from aromatic amino acids and risk of cardiovascular morbidity and mortality. Eur Heart J. 2023;44(32):3085–3096. doi:10.1093/eurheartj/ehad333.
   PubMed Web of Science ®Google Scholar
• Odamaki T, Kato K, Sugahara H, Hashikura N, Takahashi S, Xiao J-Z, Abe F, Osawa R. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. BMC Microbiol. 2016;16(1): doi:10.1186/s12866-016-0708-5.
   PubMedGoogle Scholar
• Jordan CKI, Brown RL, Larkinson MLY, Sequeira RP, Edwards AM, Clarke TB. Symbiotic firmicutes establish mutualism with the host via innate tolerance and resistance to control systemic immunity. Cell Host Microbe. 2023;31(9):1433–1449 e1439. doi:10.1016/j.chom.2023.07.008.
   PubMed Web of Science ®Google Scholar
• Zhong H, Penders J, Shi Z, Ren H, Cai K, Fang C, Ding Q, Thijs C, Blaak EE, Stehouwer CDA, et al. Impact of early events and lifestyle on the gut microbiota and metabolic phenotypes in young school-age children. Microbiome. 2019;7(1): doi:10.1186/s40168-018-0608-z.
   Google Scholar
• Hollister EB, Riehle K, Luna RA, Weidler EM, Rubio-Gonzales M, Mistretta T-A, Raza S, Doddapaneni HV, Metcalf GA, Muzny DM. et al. Structure and function of the healthy pre-adolescent pediatric gut microbiome. Microbiome. 2015;3(1):1–3. doi:10.1186/s40168-015-0101-x.
   PubMedGoogle Scholar
• Bonder MJ, Kurilshikov A, Tigchelaar EF, Mujagic Z, Imhann F, Vila AV, Deelen P, Vatanen T, Schirmer M, Smeekens SP, et al. The effect of host genetics on the gut microbiome. Nat Genet. 2016;48(11):1407–1412. doi:10.1038/ng.3663.
   PubMed Web of Science ®Google Scholar
• Tang J, Wei Y, Pi C, Zheng W, Zuo Y, Shi P, Chen J, Xiong L, Chen T, Liu H, et al. The therapeutic value of bifidobacteria in cardiovascular disease. Npj Biofilms Microbiomes. 2023;9(1):82. doi:10.1038/s41522-023-00448-7.
   PubMed Web of Science ®Google Scholar
• Rinninella E, Cintoni M, Raoul P, Lopetuso LR, Scaldaferri F, Pulcini G, Miggiano GA, Gasbarrini A, Mele MC. Food components and dietary habits: keys for a healthy gut microbiota composition. Nutrients. 2019;11(10):2393. doi:10.3390/nu11102393.
   PubMed Web of Science ®Google Scholar
• Do MH, Lee E, Oh MJ, Kim Y, Park HY. High-glucose or -fructose diet cause changes of the gut microbiota and metabolic disorders in mice without body weight change. Nutrients. 2018;10(6):761. doi:10.3390/nu10060761.
   PubMed Web of Science ®Google Scholar
• Boccella N, Paolillo R, Coretti L, D’Apice S, Lama A, Giugliano G, Schiattarella GG, Cuomo M, d’Aquino I, Cavaliere G, et al. Transverse aortic constriction induces gut barrier alterations, microbiota remodeling and systemic inflammation. Sci Rep. 2021;11(1):7404. doi:10.1038/s41598-021-86651-y.
   PubMed Web of Science ®Google Scholar
• Gubert C, Kong G, Renoir T, Hannan AJ. Exercise, diet and stress as modulators of gut microbiota: Implications for neurodegenerative diseases. Neurobiol Dis. 2020;134:104621. doi:10.1016/j.nbd.2019.104621.
   PubMed Web of Science ®Google Scholar
• Chen HC, Liu Y-W, Chang K-C, Wu Y-W, Chen Y-M, Chao Y-K, You M-Y, Lundy DJ, Lin C-J, Hsieh ML, et al. Gut butyrate-producers confer post-infarction cardiac protection. Nat Commun. 2023;14(1):7249. doi:10.1038/s41467-023-43167-5.
   PubMed Web of Science ®Google Scholar
• Chen W, Zhang S, Wu J, Ye T, Wang S, Wang P, Xing D. Butyrate-producing bacteria and the gut-heart axis in atherosclerosis. Clin Chim Acta. 2020;507:236–241. doi:10.1016/j.cca.2020.04.037.
   PubMed Web of Science ®Google Scholar
• Wang F, Qian F, Zhang Q, Zhao J, Cen J, Zhang J, Zhou J, Luo M, Jia C, Rong X, et al. The reduced SCFA-producing gut microbes are involved in the inflammatory activation in Kawasaki disease. Front Immunol. 2023;14:1124118. doi:10.3389/fimmu.2023.1124118.
   PubMed Web of Science ®Google Scholar
• Greco A, De Virgilio A, Rizzo MI, Tombolini M, Gallo A, Fusconi M, Ruoppolo G, Pagliuca G, Martellucci S, de Vincentiis M, et al. Kawasaki disease: an evolving paradigm. Autoimmun Rev. 2015;14(8):703–709. doi:10.1016/j.autrev.2015.04.002.
   PubMed Web of Science ®Google Scholar
• Nagata S, Yamashiro Y, Ohtsuka Y, Shimizu T, Sakurai Y, Misawa S, Ito T. Heat shock proteins and superantigenic properties of bacteria from the gastrointestinal tract of patients with Kawasaki disease. Immunology. 2009;128(4):511–520. doi:10.1111/j.1365-2567.2009.03135.x.
   PubMed Web of Science ®Google Scholar
• Hu X, Fan R, Song W, Qing J, Yan X, Li Y, Duan Q, Li Y. Landscape of intestinal microbiota in patients with IgA nephropathy, IgA vasculitis and Kawasaki disease. Front Cell Infect Microbiol. 2022;12:1061629. doi:10.3389/fcimb.2022.1061629.
   PubMed Web of Science ®Google Scholar
• Kinumaki A, Sekizuka T, Hamada H, Kato K, Yamashita A, Kuroda M. Characterization of the gut microbiota of Kawasaki disease patients by metagenomic analysis. Front Microbiol. 2015;6:824. doi:10.3389/fmicb.2015.00824.
   PubMed Web of Science ®Google Scholar
• Haak BW, Littmann ER, Chaubard J-L, Pickard AJ, Fontana E, Adhi F, Gyaltshen Y, Ling L, Morjaria SM, Peled JU, et al. Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT. Blood. 2018;131:2978–2986. doi:10.1182/blood-2018-01-828996.
   PubMed Web of Science ®Google Scholar
• Xiang K, Wang P, Xu Z, Hu Y-Q, He Y-S, Chen Y, Feng Y-T, Yin K-J, Huang J-X, Wang J, et al. Causal effects of gut microbiome on systemic lupus erythematosus: a two-sample mendelian randomization study. Front Immunol. 2021;12:667097. doi:10.3389/fimmu.2021.667097.
   PubMed Web of Science ®Google Scholar
• Koh A, De Vadder F, Kovatcheva-Datchary P, Backhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016;165(6):1332–1345. doi:10.1016/j.cell.2016.05.041.
   PubMed Web of Science ®Google Scholar
• Kasahara K, Krautkramer KA, Org E, Romano KA, Kerby RL, Vivas EI, Mehrabian M, Denu JM, Bäckhed F, Lusis AJ, et al. Interactions between Roseburia intestinalis and diet modulate atherogenesis in a murine model. Nat Microbiol. 2018;3(12):1461–1471. doi:10.1038/s41564-018-0272-x.
   PubMed Web of Science ®Google Scholar
• Kaneko K, Akagawa S, Akagawa Y, Kimata T, Tsuji S. Our evolving understanding of Kawasaki disease pathogenesis: role of the gut microbiota. Front Immunol. 2020;11:1616. doi:10.3389/fimmu.2020.01616.
   PubMed Web of Science ®Google Scholar
• Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet. 2014;383(9911):69–82. doi:10.1016/S0140-6736(13)60591-7.
   PubMed Web of Science ®Google Scholar
• Vatanen T, Franzosa EA, Schwager R, Tripathi S, Arthur TD, Vehik K, Lernmark Å, Hagopian WA, Rewers MJ, She J-X, et al. The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature. 2018;562(7728):589–594. doi:10.1038/s41586-018-0620-2.
   PubMed Web of Science ®Google Scholar
• Murri M, Leiva I, Gomez-Zumaquero JM, Tinahones FJ, Cardona F, Soriguer F, Queipo-Ortuño MI. Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med. 2013;11(1):46. doi:10.1186/1741-7015-11-46.
   PubMed Web of Science ®Google Scholar
• Yuan X, Wang R, Han B, Sun C, Chen R, Wei H, Chen L, Du H, Li G, Yang Y, et al. Functional and metabolic alterations of gut microbiota in children with new-onset type 1 diabetes. Nat Commun. 2022;13(1):6356. doi:10.1038/s41467-022-33656-4.
   PubMed Web of Science ®Google Scholar
• Mohammad S, Thiemermann C. Role of metabolic endotoxemia in systemic inflammation and potential interventions. Front Immunol. 2020;11:594150. doi:10.3389/fimmu.2020.594150.
   PubMed Web of Science ®Google Scholar
• de Groot P, Nikolic T, Pellegrini S, Sordi V, Imangaliyev S, Rampanelli E, Hanssen N, Attaye I, Bakker G, Duinkerken G, et al. Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial. Gut. 2021;70(1):92–105. doi:10.1136/gutjnl-2020-322630.
   PubMed Web of Science ®Google Scholar
• Su Z, Zhang Y, Cai X, Li Q, Gu H, Luan Y, He Y, Li S, Chen J, Zhang H, et al. Improving long-term care and outcomes of congenital heart disease: fulfilling the promise of a healthy life. Lancet Child Adolesc Health. 2023;7(7):502–518. doi:10.1016/S2352-4642(23)00053-6.
   PubMedGoogle Scholar
• Zeng X, An J, Lin R, Dong C, Zheng A, Li J, Duan H, Shu Q, Li H. Prediction of complications after paediatric cardiac surgery. Eur J Cardiothorac Surg. 2020;57(2):350–358. doi:10.1093/ejcts/ezz198.
   PubMed Web of Science ®Google Scholar
• Carrillo-Salinas FJ, Anastasiou M, Ngwenyama N, Kaur K, Tai A, Smolgovsky SA, Jetton D, Aronovitz M, Alcaide P. Gut dysbiosis induced by cardiac pressure overload enhances adverse cardiac remodeling in a T cell-dependent manner. Gut Microbes. 2020;12(1):1–20. doi:10.1080/19490976.2020.1823801.
   PubMed Web of Science ®Google Scholar
• Lin CJ, Cheng Y-C, Chen H-C, Chao Y-K, Nicholson MW, Yen ECL, Kamp TJ, Hsieh PCH. Commensal gut microbiota-derived acetate and propionate enhance heart adaptation in response to cardiac pressure overload in mice. Theranostics. 2022;12(17):7319–7334. doi:10.7150/thno.76002.
   PubMed Web of Science ®Google Scholar
• DeJong EN, Surette MG, Bowdish DME. The gut microbiota and unhealthy aging: disentangling cause from consequence. Cell Host Microbe. 2020;28(2):180–189. doi:10.1016/j.chom.2020.07.013.
   PubMed Web of Science ®Google Scholar
• de la Cuesta-Zuluaga J, Kelley ST, Chen Y, Escobar JS, Mueller NT, Ley RE, McDonald D, Huang S, Swafford AD, Knight R. et al. Age- and sex-dependent patterns of gut microbial diversity in human adults. mSystems. 2019;4(4):10–128. doi:10.1128/mSystems.00261-19.
   Web of Science ®Google Scholar
• Liu BN, Liu XT, Liang ZH, Wang JH. Gut microbiota in obesity. World J Gastroenterol. 2021;27(25):3837–3850. doi:10.3748/wjg.v27.i25.3837.
   PubMed Web of Science ®Google Scholar
• Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto J-M. et al. Enterotypes of the human gut microbiome. Nature. 2011;473(7346):174–180. doi:10.1038/nature09944.
   PubMed Web of Science ®Google Scholar
• Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G, Wu S, Liu W, Cui Q, Geng B, et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017;5(1):1–9. doi:10.1186/s40168-016-0222-x.
   PubMedGoogle Scholar
• Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, Nalin R, Jarrin C, Chardon P, Marteau P, et al. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach. Gut. 2006;55:205–211. doi:10.1136/gut.2005.073817.
   PubMed Web of Science ®Google Scholar
• Frank DN, St. Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007;104(34):13780–13785. doi:10.1073/pnas.0706625104.
   PubMed Web of Science ®Google Scholar
• Simpson CA, Diaz-Arteche C, Eliby D, Schwartz OS, Simmons JG, Cowan CSM. The gut microbiota in anxiety and depression – a systematic review. Clin Psychol Rev. 2021;83:101943. doi:10.1016/j.cpr.2020.101943.
   PubMed Web of Science ®Google Scholar
• Benowitz NL, Liakoni E. Tobacco use disorder and cardiovascular health. Addiction. 2022;117(4):1128–1138. doi:10.1111/add.15703.
   PubMed Web of Science ®Google Scholar
• Antinozzi M, Giffi M, Sini N, Gallè F, Valeriani F, De Vito C, Liguori G, Romano Spica V, Cattaruzza MS. Cigarette Smoking and Human Gut Microbiota in Healthy Adults: A Systematic Review. Biomedicines. 2022;10(2):510. doi:10.3390/biomedicines10020510.
   PubMed Web of Science ®Google Scholar
• Fan J, Zhou Y, Meng R, Tang J, Zhu J, Aldrich MC, Cox NJ, Zhu Y, Li Y, Zhou D, et al. Cross-talks between gut microbiota and tobacco smoking: a two-sample Mendelian randomization study. BMC Med. 2023;21(1):163. doi:10.1186/s12916-023-02863-1.
   PubMed Web of Science ®Google Scholar
• Bai X, Wei H, Liu W, Coker OO, Gou H, Liu C, Zhao L, Li C, Zhou Y, Wang G, et al. Cigarette smoke promotes colorectal cancer through modulation of gut microbiota and related metabolites. Gut. 2022;71(12):2439–2450. doi:10.1136/gutjnl-2021-325021.
   PubMed Web of Science ®Google Scholar
• Lakosa A, Rahimian A, Tomasi F, Marti F, Reynolds LM, Tochon L, David V, Danckaert A, Canonne C, Tahraoui S, et al. Impact of the gut microbiome on nicotine’s motivational effects and glial cells in the ventral tegmental area in male mice. Neuropsychopharmacology. 2023;48(6):963–974. doi:10.1038/s41386-023-01563-x.
   PubMed Web of Science ®Google Scholar
• Chakrabarti A, Geurts L, Hoyles L, Iozzo P, Kraneveld AD, La Fata G, Miani M, Patterson E, Pot B, Shortt C, et al. The microbiota–gut–brain axis: pathways to better brain health. Perspectives on what we know, what we need to investigate and how to put knowledge into practice. Cell Mol Life Sci. 2022;79(2):80. doi:10.1007/s00018-021-04060-w.
   PubMed Web of Science ®Google Scholar
• Rodrigues VST, Moura EG, Peixoto TC, Soares PN, Lopes BP, Oliveira E, Manhães AC, Atella GC, Kluck GEG, Cabral SS, et al. Changes in gut-brain axis parameters in adult rats of both sexes with different feeding pattern that were early nicotine-exposed. Food Chem Toxicol. 2021;158:112656. doi:10.1016/j.fct.2021.112656.
   PubMed Web of Science ®Google Scholar
• Chen B, Sun L, Zeng G, Shen Z, Wang K, Yin L, Xu F, Wang P, Ding Y, Nie Q, et al. Gut bacteria alleviate smoking-related NASH by degrading gut nicotine. Nature. 2022;610(7932):562–568. doi:10.1038/s41586-022-05299-4.
   PubMed Web of Science ®Google Scholar
• Chaurasia B, Summers SA. Ceramides in Metabolism: Key Lipotoxic Players. Annu Rev Physiol. 2021;83(1):303–330. doi:10.1146/annurev-physiol-031620-093815.
   PubMedGoogle Scholar
• Sasset L, Manzo OL, Zhang Y, Marino A, Rubinelli L, Riemma MA, Chalasani MLS, Dasoveanu DC, Roviezzo F, Jankauskas SS, et al. Nogo-A reduces ceramide de novo biosynthesis to protect from heart failure. Cardiovasc Res. 2023;119(2):506–519. doi:10.1093/cvr/cvac108.
   Web of Science ®Google Scholar
• Zietzer A, Dusing P, Reese L, Nickenig G, Jansen F. Ceramide metabolism in cardiovascular disease: a network with high therapeutic potential. Arterioscler Thromb Vasc Biol. 2022;42(10):1220–1228. doi:10.1161/ATVBAHA.122.318048.
   PubMed Web of Science ®Google Scholar
• Katta N, Loethen T, Lavie CJ, Alpert MA. Obesity and coronary heart disease: epidemiology, pathology, and coronary artery imaging. Curr Probl Cardiol. 2021;46(3):100655. doi:10.1016/j.cpcardiol.2020.100655.
   PubMed Web of Science ®Google Scholar
• Thingholm LB, Rühlemann MC, Koch M, Fuqua B, Laucke G, Boehm R, Bang C, Franzosa EA, Hübenthal M, Rahnavard A, et al. Obese individuals with and without type 2 diabetes show different gut microbial functional capacity and composition. Cell Host Microbe. 2019;26(2):252–264 e210. doi:10.1016/j.chom.2019.07.004.
   PubMed Web of Science ®Google Scholar
• Rodrigues VF, Elias-Oliveira J, Pereira ÍS, Pereira JA, Barbosa SC, Machado MSG, Carlos D. Akkermansia muciniphila and gut immune system: a good friendship that attenuates inflammatory bowel disease, obesity, and diabetes. Front Immunol. 2022;13:934695. doi:10.3389/fimmu.2022.934695.
   PubMed Web of Science ®Google Scholar
• Zahavi L, Lavon A, Reicher L, Shoer S, Godneva A, Leviatan S, Rein M, Weissbrod O, Weinberger A, Segal E, et al. Bacterial SNPs in the human gut microbiome associate with host BMI. Nat Med. 2023;29(11):2785–2792. doi:10.1038/s41591-023-02599-8.
   Google Scholar
• Li HB, Xu M-L, Xu X-D, Tang Y-Y, Jiang H-L, Li L, Xia W-J, Cui N, Bai J, Dai Z-M, et al. Faecalibacterium prausnitzii attenuates CKD via butyrate-renal GPR43 axis. Circ Res. 2022;131(9):e120–e134. doi:10.1161/CIRCRESAHA.122.320184.
   Web of Science ®Google Scholar
• Takeuchi T, Kameyama K, Miyauchi E, Nakanishi Y, Kanaya T, Fujii T, Kato T, Sasaki T, Tachibana N, Negishi H, et al. Fatty acid overproduction by gut commensal microbiota exacerbates obesity. Cell Metab. 2023;35(2):361–375 e369. doi:10.1016/j.cmet.2022.12.013.
   PubMed Web of Science ®Google Scholar
• Gupta A, Osadchiy V, Mayer EA. Brain–gut–microbiome interactions in obesity and food addiction. Nat Rev Gastroenterol Hepatol. 2020;17(11):655–672. doi:10.1038/s41575-020-0341-5.
   PubMed Web of Science ®Google Scholar
• Ussher JR, Drucker DJ. Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action. Nat Rev Cardiol. 2023;20(7):463–474. doi:10.1038/s41569-023-00849-3.
   Web of Science ®Google Scholar
• Tazi A, Araujo JR, Mulet C, Arena ET, Nigro G, Pédron T, Sansonetti PJ. Disentangling host-microbiota regulation of lipid secretion by enterocytes: insights from commensals lactobacillus paracasei and Escherichia coli. mBio. 2018;9(5):10–128. doi:10.1128/mBio.01493-18.
   Web of Science ®Google Scholar
• Lee M, Kim YS, Park J, Choe G, Lee S, Kang BG, Jun JH, Shin Y, Kim M, Ahn Y, et al. A paintable and adhesive hydrogel cardiac patch with sustained release of ANGPTL4 for infarcted heart repair. Bioact Mater. 2024;31:395–407. doi:10.1016/j.bioactmat.2023.08.020.
   Web of Science ®Google Scholar
• Yang J, Li X, Xu D. Research progress on the involvement of ANGPTL4 and loss-of-function variants in lipid metabolism and coronary heart disease: is the “prime time” of ANGPTL4-targeted therapy for coronary heart disease approaching? Cardiovasc Drugs Ther. 2021;35(3):467–477. doi:10.1007/s10557-020-07001-0.
   Web of Science ®Google Scholar
• Weninger SN, Herman C, Meyer RK, Beauchemin ET, Kangath A, Lane AI, Martinez TM, Hasneen T, Jaramillo SA, Lindsey J, et al. Oligofructose improves small intestinal lipid-sensing mechanisms via alterations to the small intestinal microbiota. Microbiome. 2023;11(1):169. doi:10.1186/s40168-023-01590-2.
   Web of Science ®Google Scholar
• Shelton CD, Sing E, Mo J, Shealy NG, Yoo W, Thomas J, Fitz GN, Castro PR, Hickman TT, Torres TP, et al. An early-life microbiota metabolite protects against obesity by regulating intestinal lipid metabolism. Cell Host Microbe. 2023;31(10):1604–1619 e1610. doi:10.1016/j.chom.2023.09.002.
   Web of Science ®Google Scholar
• Muller M, Cooper LT, Heidecker B. Diagnosis, risk stratification and management of myocarditis. Heart. 2022;108(18):1486–1497. doi:10.1136/heartjnl-2021-319027.
   Web of Science ®Google Scholar
• Hu XF, Zhang W-Y, Wen Q, Chen W-J, Wang Z-M, Chen J, Zhu F, Liu K, Cheng L-X, Yang J, et al. Fecal microbiota transplantation alleviates myocardial damage in myocarditis by restoring the microbiota composition. Pharmacol Res. 2019;139:412–421. doi:10.1016/j.phrs.2018.11.042.
   PubMed Web of Science ®Google Scholar
• Luo Q, Hu Y, Chen X, Luo Y, Chen J, Wang H. Effects of gut microbiota and metabolites on heart failure and its risk factors: a two-sample mendelian randomization study. Front Nutr. 2022;9:899746. doi:10.3389/fnut.2022.899746.
   Web of Science ®Google Scholar
• Myers JM, Cooper LT, Kem DC, Stavrakis S, Kosanke SD, Shevach EM, Fairweather D, Stoner JA, Cox CJ, Cunningham MW, et al. Cardiac myosin-Th17 responses promote heart failure in human myocarditis. JCI Insight. 2016;1(9). doi:10.1172/jci.insight.85851.
   Web of Science ®Google Scholar
• Gil-Cruz C, Perez-Shibayama C, De Martin A, Ronchi F, van der Borght K, Niederer R, Onder L, Lütge M, Novkovic M, Nindl V, et al. Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy. Science. 2019;366(6467):881–886. doi:10.1126/science.aav3487.
   PubMed Web of Science ®Google Scholar
• Mandelbaum N, Gefen T, Geva-Zatorsky N. Gut bacteria—not for the faint of heart. Cell Host Microbe. 2020;27(1):1–3. doi:10.1016/j.chom.2019.12.011.
   Web of Science ®Google Scholar
• Tian Y, Liu J, Zhao Y, Jiang N, Liu X, Zhao G, Wang X. Alcohol consumption and all-cause and cause-specific mortality among US adults: prospective cohort study. BMC Med. 2023;21(1):208. doi:10.1186/s12916-023-02907-6.
   Web of Science ®Google Scholar
• O’Keefe EL, DiNicolantonio JJ, O’Keefe JH, Lavie CJ. Alcohol and CV health: Jekyll and Hyde J-Curves. Prog Cardiovasc Dis. 2018;61(1):68–75. doi:10.1016/j.pcad.2018.02.001.
   PubMed Web of Science ®Google Scholar
• Leclercq S, Matamoros S, Cani PD, Neyrinck AM, Jamar F, Stärkel P, Windey K, Tremaroli V, Bäckhed F, Verbeke K, et al. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc Natl Acad Sci U S A. 2014;111(42):E4485–4493. doi:10.1073/pnas.1415174111.
   PubMed Web of Science ®Google Scholar
• Giuffre M, Campigotto M, Campisciano G, Comar M, Croce LS. A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literature. Am J Physiol Gastrointest Liver Physiol. 2020;318(5):G889–G906. doi:10.1152/ajpgi.00161.2019.
   PubMed Web of Science ®Google Scholar
• Moreira Junior RE, de Carvalho LM, Pedersen ASB, Damasceno S, Maioli TU, de Faria AMC, Godard ALB. Interaction between high-fat diet and ethanol intake leads to changes on the fecal microbiome. J Nutr Biochem. 2019;72:108215. doi:10.1016/j.jnutbio.2019.07.006.
   Web of Science ®Google Scholar
• Dubinkina VB, Tyakht AV, Odintsova VY, Yarygin KS, Kovarsky BA, Pavlenko AV, Ischenko DS, Popenko AS, Alexeev DG, Taraskina AY, et al. Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease. Microbiome. 2017;5(1):141. doi:10.1186/s40168-017-0359-2.
   PubMed Web of Science ®Google Scholar
• Xie G, Zhong W, Li H, Li Q, Qiu Y, Zheng X, Chen H, Zhao X, Zhang S, Zhou Z, et al. Alteration of bile acid metabolism in the rat induced by chronic ethanol consumption. FASEB J. 2013;27(9):3583–3593. doi:10.1096/fj.13-231860.
   PubMed Web of Science ®Google Scholar
• Molina PE, Gardner JD, Souza-Smith FM, Whitaker AM. Alcohol abuse: critical pathophysiological processes and contribution to disease burden. Physiol (Bethesda). 2014;29(3):203–215. doi:10.1152/physiol.00055.2013.
   PubMed Web of Science ®Google Scholar
• Liu Y, Chen K, Li F, Gu Z, Liu Q, He L, Shao T, Song Q, Zhu F, Zhang L, et al. Probiotic lactobacillus rhamnosus GG prevents liver fibrosis through inhibiting hepatic bile acid synthesis and enhancing bile acid excretion in mice. Hepatology. 2020;71(6):2050–2066. doi:10.1002/hep.30975.
   PubMed Web of Science ®Google Scholar
• Qi Y, Han X, Zhao D, Wang W, Wang M, Sun J, Liu J, Li Y, Gao S, Hao Y, et al. Long-term cardiovascular risk associated with stage 1 hypertension defined by the 2017 ACC/AHA hypertension guideline. J Am Coll Cardiol. 2018;72(11):1201–1210. doi:10.1016/j.jacc.2018.06.056.
   PubMed Web of Science ®Google Scholar
• Yang Z, Wang Q, Liu Y, Wang L, Ge Z, Li Z, Feng S, Wu C. Gut microbiota and hypertension: association, mechanisms and treatment. Clin Exp Hypertens. 2023;45(1):2195135. doi:10.1080/10641963.2023.2195135.
   PubMed Web of Science ®Google Scholar
• Kim S, Goel R, Kumar A, Qi Y, Lobaton G, Hosaka K, Mohammed M, Handberg E, Richards E, Pepine C, et al. Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure. Clin Sci (Lond). 2018;132(6):701–718. doi:10.1042/CS20180087.
   PubMed Web of Science ®Google Scholar
• Rath S, Heidrich B, Pieper DH, Vital M. Uncovering the trimethylamine-producing bacteria of the human gut microbiota. Microbiome. 2017;5(1):1–4. doi:10.1186/s40168-017-0271-9.
   PubMedGoogle Scholar
• Zhang Y, Wang Y, Ke B, Du J. TMAO: how gut microbiota contributes to heart failure. Transl Res. 2021;228:109–125. doi:10.1016/j.trsl.2020.08.007.
   PubMed Web of Science ®Google Scholar
• Ge X, Zheng L, Zhuang R, Yu P, Xu Z, Liu G, Xi X, Zhou X, Fan H. The gut microbial metabolite trimethylamine N-Oxide and hypertension risk: a systematic review and dose–response meta-analysis. Adv Nutr. 2020;11(1):66–76. doi:10.1093/advances/nmz064.
   PubMed Web of Science ®Google Scholar
• Jiang S, Shui Y, Cui Y, Tang C, Wang X, Qiu X, Hu W, Fei L, Li Y, Zhang S, et al. Gut microbiota dependent trimethylamine N-oxide aggravates angiotensin II–induced hypertension. Redox Biol. 2021;46:102115. doi:10.1016/j.redox.2021.102115.
   PubMed Web of Science ®Google Scholar
• Tang WHW, Li DY, Hazen SL. Dietary metabolism, the gut microbiome, and heart failure. Nat Rev Cardiol. 2019;16(3):137–154. doi:10.1038/s41569-018-0108-7.
   PubMed Web of Science ®Google Scholar
• Witkowski M, Weeks TL, Hazen SL. Gut microbiota and cardiovascular disease. Circ Res. 2020;127(4):553–570. doi:10.1161/CIRCRESAHA.120.316242.
   PubMed Web of Science ®Google Scholar
• Mancin L, Wu GD, Paoli A. Gut microbiota–bile acid–skeletal muscle axis. Trends Microbiol. 2023;31(3):254–269. doi:10.1016/j.tim.2022.10.003.
   PubMed Web of Science ®Google Scholar
• Fiorucci S, Zampella A, Cirino G, Bucci M, Distrutti E. Decoding the vasoregulatory activities of bile acid-activated receptors in systemic and portal circulation: role of gaseous mediators. Am J Physiol Heart Circ Physiol. 2017;312(1):H21–H32. doi:10.1152/ajpheart.00577.2016.
   PubMed Web of Science ®Google Scholar
• Marques FZ, Nelson E, Chu P-Y, Horlock D, Fiedler A, Ziemann M, Tan JK, Kuruppu S, Rajapakse NW, El-Osta A, et al. High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice. Circulation. 2017;135(10):964–977. doi:10.1161/CIRCULATIONAHA.116.024545.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhao J, Tian C, Chen X, Li H, Wei X, Lin W, Zheng N, Jiang A, Feng R, et al. Targeting the gut microbiota to investigate the mechanism of lactulose in negating the effects of a high-salt diet on hypertension. Mol Nutr Food Res. 2019;63(11):e1800941. doi:10.1002/mnfr.201800941.
   Web of Science ®Google Scholar
• Zhu Q, Zhu Y, Liu Y, Tao Y, Lin Y, Lai S, Liang Z, Chen Y, Chen Y, Wang L, et al. Moderation of gut microbiota and bile acid metabolism by chlorogenic acid improves high-fructose-induced salt-sensitive hypertension in mice. Food Funct. 2022;13(13):6987–6999. doi:10.1039/D2FO00038E.
   Web of Science ®Google Scholar
• Zhou Z, Sun B, Yu D, Zhu C. Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus. Front Cell Infect Microbiol. 2022;12:834485. doi:10.3389/fcimb.2022.834485.
   PubMed Web of Science ®Google Scholar
• Chen PC, Chien YW, Yang SC. The alteration of gut microbiota in newly diagnosed type 2 diabetic patients. Nutrition. 2019;63-64:51–56. doi:10.1016/j.nut.2018.11.019.
   PubMed Web of Science ®Google Scholar
• Koh A, Molinaro A, Ståhlman M, Khan MT, Schmidt C, Mannerås-Holm L, Wu H, Carreras A, Jeong H, Olofsson LE, et al. Microbially produced imidazole propionate impairs insulin signaling through mTORC1. Cell. 2018;175(4):947–961 e917. doi:10.1016/j.cell.2018.09.055.
   PubMed Web of Science ®Google Scholar
• You H, Tan Y, Yu D, Qiu S, Bai Y, He J, Cao H, Che Q, Guo J, Su Z, et al. The therapeutic effect of SCFA-Mediated regulation of the intestinal environment on obesity. Front Nutr. 2022;9:886902. doi:10.3389/fnut.2022.886902.
   PubMed Web of Science ®Google Scholar
• Gribble FM, Reimann F. Enteroendocrine cells: chemosensors in the intestinal epithelium. Annu Rev Physiol. 2016;78(1):277–299. doi:10.1146/annurev-physiol-021115-105439.
   PubMedGoogle Scholar
• Mancin L, Wu GD, Paoli A. Gut microbiota–bile acid–skeletal muscle axis. Trends Microbiol. 2023;31(3):322. doi:10.1016/j.tim.2023.01.003.
   Web of Science ®Google Scholar
• Correale M, Lamacchia O, Ciccarelli M, Dattilo G, Tricarico L, Brunetti ND. Vascular and metabolic effects of SGLT2i and GLP-1 in heart failure patients. Heart Fail Rev. 2023;28(3):733–744. doi:10.1007/s10741-021-10157-y.
   Web of Science ®Google Scholar
• Chen ML, Zhu X-H, Ran L, Lang H-D, Yi L, Mi M-T. Trimethylamine-N-Oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3-SOD2-mtROS signaling pathway. J Am Heart Assoc. 2017;6(9):e006347. doi:10.1161/JAHA.117.006347.
   PubMed Web of Science ®Google Scholar
• Seldin MM, Meng Y, Qi H, Zhu W, Wang Z, Hazen SL, Lusis AJ, Shih DM. Trimethylamine N-Oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear factor-κB. J Am Heart Assoc. 2016;5(2):e002767. doi:10.1161/JAHA.115.002767.
   PubMed Web of Science ®Google Scholar
• Adak A, Khan MR. An insight into gut microbiota and its functionalities. Cell Mol Life Sci. 2019;76(3):473–493. doi:10.1007/s00018-018-2943-4.
   PubMed Web of Science ®Google Scholar
• Paik D, Yao L, Zhang Y, Bae S, D’Agostino GD, Zhang M, Kim E, Franzosa EA, Avila-Pacheco J, Bisanz JE, et al. Human gut bacteria produce ΤΗ17-modulating bile acid metabolites. Nature. 2022;603(7903):907–912. doi:10.1038/s41586-022-04480-z.
   PubMed Web of Science ®Google Scholar
• Zhai L, Wu J, Lam YY, Kwan HY, Bian Z-X, Wong HLX. Gut-microbial metabolites, probiotics and their roles in type 2 diabetes. Int J Mol Sci. 2021;22(23):12846. doi:10.3390/ijms222312846.
   Web of Science ®Google Scholar
• Li X, Wang N, Yin B, Fang D, Jiang T, Fang S, Zhao J, Zhang H, Wang G, Chen W, et al. Effects of lactobacillus plantarum CCFM0236 on hyperglycaemia and insulin resistance in high-fat and streptozotocin-induced type 2 diabetic mice. J Appl Microbiol. 2016;121(6):1727–1736. doi:10.1111/jam.13276.
   PubMed Web of Science ®Google Scholar
• Balakumar M, Prabhu D, Sathishkumar C, Prabu P, Rokana N, Kumar R, Raghavan S, Soundarajan A, Grover S, Batish VK, et al. Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice. Eur J Nutr. 2018;57(1):279–295. doi:10.1007/s00394-016-1317-7.
   PubMed Web of Science ®Google Scholar
• Aluru JS, Barsouk A, Saginala K, Rawla P, Barsouk A. Valvular Heart Disease Epidemiology. Med Sci (Basel). 2022;10(2):32. doi:10.3390/medsci10020032.
   Google Scholar
• Pawade TA, Newby DE, Dweck MR. Calcification in Aortic Stenosis: The Skeleton Key. J Am Coll Cardiol. 2015;66(5):561–577. doi:10.1016/j.jacc.2015.05.066.
   PubMed Web of Science ®Google Scholar
• Fulop P, Dvorožňáková M, Vachalcová M, Fülöpová Z, Šoltys K, Valočik G. Gut microbiome in heart failure and aortic stenosis. Vnitr Lek. 2022;68(2):4–10. doi:10.36290/vnl.2022.026.
   Google Scholar
• Guo Y, Xu S, Zhan H, Chen H, Hu P, Zhou D, Dai H, Liu X, Hu W, Zhu G, et al. Trimethylamine N-Oxide levels are associated with severe aortic stenosis and predict long-term adverse outcome. J Clin Med. 2023;12(2):407. doi:10.3390/jcm12020407.
   Web of Science ®Google Scholar
• Kocyigit D, Tokgozoglu L, Gurses KM, Stahlman M, Boren J, Soyal MFT, Canpınar H, Guc D, Saglam Ayhan A, Hazirolan T, et al. Association of dietary and gut microbiota-related metabolites with calcific aortic stenosis. Acta Cardiol. 2021;76(5):544–552. doi:10.1080/00015385.2020.1853968.
   PubMed Web of Science ®Google Scholar
• Taslim NA, Yusuf M, Ambari AM, Del Rosario Puling IM, Ibrahim FZ, Hardinsyah H, Kurniawan R, Gunawan WB, Mayulu N, Joseph VFF, et al. Anti-inflammatory, antioxidant, metabolic and gut microbiota modulation activities of probiotic in cardiac remodeling condition: evidence from systematic study and meta-analysis of randomized controlled trials. Probiotics Antimicrob Proteins. 2023;15(4):1049–1061. doi:10.1007/s12602-023-10105-2.
   Web of Science ®Google Scholar
• Karmazyn M, Gan XT. Probiotics as potential treatments to reduce myocardial remodelling and heart failure via the gut-heart axis: state-of-the-art review. Mol Cell Biochem. 2023;478(11):2539–2551. doi:10.1007/s11010-023-04683-6.
   Web of Science ®Google Scholar
• Dooley LM, Ahmad TB, Pandey M, Good MF, Kotiw M. Rheumatic heart disease: a review of the current status of global research activity. Autoimmun Rev. 2021;20(2):102740. doi:10.1016/j.autrev.2020.102740.
   PubMed Web of Science ®Google Scholar
• Dougherty S, Okello E, Mwangi J, Kumar RK. Rheumatic heart disease: JACC focus seminar 2/4. J Am Coll Cardiol. 2023;81(1):81–94. doi:10.1016/j.jacc.2022.09.050.
   Web of Science ®Google Scholar
• Shi XR, Chen B-Y, Lin W-Z, Li Y-L, Wang Y-L, Liu Y, Huang J-J, Zhang W-W, Ma X-X, Shao S, et al. Microbiota in gut, oral cavity, and mitral valves are associated with rheumatic heart disease. Front Cell Infect Microbiol. 2021;11:643092. doi:10.3389/fcimb.2021.643092.
   PubMed Web of Science ®Google Scholar
• Liberale L, Badimon L, Montecucco F, Lüscher TF, Libby P, Camici GG. Inflammation, aging, and cardiovascular disease: JACC review topic of the Week. J Am Coll Cardiol. 2022;79(8):837–847. doi:10.1016/j.jacc.2021.12.017.
   PubMed Web of Science ®Google Scholar
• Fleg JL, Aronow WS, Frishman WH. Cardiovascular drug therapy in the elderly: benefits and challenges. Nat Rev Cardiol. 2011;8(1):13–28. doi:10.1038/nrcardio.2010.162.
   PubMed Web of Science ®Google Scholar
• Badal VD, Vaccariello ED, Murray ER, Yu KE, Knight R, Jeste DV, Nguyen TT. The gut microbiome, aging, and longevity: a systematic review. Nutrients. 2020;12(12):3759. doi:10.3390/nu12123759.
   PubMed Web of Science ®Google Scholar
• Chronic Kidney Disease Prognosis C. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375:2073–2081. doi:10.1016/S0140-6736(10)60674-5.
   PubMed Web of Science ®Google Scholar
• Ruiz-Ortega M, Rayego-Mateos S, Lamas S, Ortiz A, Rodrigues-Diez RR. Targeting the progression of chronic kidney disease. Nat Rev Nephrol. 2020;16(5):269–288. doi:10.1038/s41581-019-0248-y.
   PubMed Web of Science ®Google Scholar
• Wang H, Ainiwaer A, Song Y, Qin L, Peng A, Bao H, Qin H. Perturbed gut microbiome and fecal and serum metabolomes are associated with chronic kidney disease severity. Microbiome. 2023;11(1):3. doi:10.1186/s40168-022-01443-4.
   PubMed Web of Science ®Google Scholar
• Huang Y, Zhou J, Wang S, Xiong J, Chen Y, Liu Y, Xiao T, Li Y, He T, Li Y, et al. Indoxyl sulfate induces intestinal barrier injury through IRF1-DRP1 axis-mediated mitophagy impairment. Theranostics. 2020;10(16):7384–7400. doi:10.7150/thno.45455.
   PubMed Web of Science ®Google Scholar
• Tang WH, Wang Z, Kennedy DJ, Wu Y, Buffa JA, Agatisa-Boyle B, Li XS, Levison BS, Hazen SL. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res. 2015;116(3):448–455. doi:10.1161/CIRCRESAHA.116.305360.
   PubMed Web of Science ®Google Scholar
• Yang T, Richards EM, Pepine CJ, Raizada MK. The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease. Nat Rev Nephrol. 2018;14(7):442–456. doi:10.1038/s41581-018-0018-2.
   PubMed Web of Science ®Google Scholar
• Rossi M, Johnson DW, Morrison M, Pascoe EM, Coombes JS, Forbes JM, Szeto C-C, McWhinney BC, Ungerer JPJ, Campbell KL, et al. Synbiotics easing renal failure by improving gut microbiology (SYNERGY): a randomized trial. Clin J Am Soc Nephrol. 2016;11(2):223–231. doi:10.2215/CJN.05240515.
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, et al. Heart disease and stroke statistics—2017 update: a report from the American heart association. Circulation. 2017;135(10):e146–e603. doi:10.1161/CIR.0000000000000485.
   PubMed Web of Science ®Google Scholar
• Liu H, Zhuang J, Tang P, Li J, Xiong X, Deng H. The role of the gut microbiota in coronary heart disease. Curr Atheroscler Rep. 2020;22(77):1–2. doi:10.1007/s11883-020-00892-2.
   Google Scholar
• Jie Z, Xia H, Zhong S-L, Feng Q, Li S, Liang S, Zhong H, Liu Z, Gao Y, Zhao H, et al. The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun. 2017;8(1):845. doi:10.1038/s41467-017-00900-1.
   PubMed Web of Science ®Google Scholar
• Geng J, Yang C, Wang B, Zhang X, Hu T, Gu Y, Li J. Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK/JNK pathway. Biomed Pharmacother. 2018;97:941–947. doi:10.1016/j.biopha.2017.11.016.
   PubMed Web of Science ®Google Scholar
• Mohammadi A, Vahabzadeh Z, Jamalzadeh S, Khalili T. Trimethylamine-N-oxide, as a risk factor for atherosclerosis, induces stress in J774A.1 murine macrophages. Adv Med Sci. 2018;63(1):57–63. doi:10.1016/j.advms.2017.06.006.
   Web of Science ®Google Scholar
• Zhu W, Gregory JC, Org E, Buffa JA, Gupta N, Wang Z, Li L, Fu X, Wu Y, Mehrabian M, et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell. 2016;165(1):111–124. doi:10.1016/j.cell.2016.02.011.
   PubMed Web of Science ®Google Scholar
• Nemet I, Saha PP, Gupta N, Zhu W, Romano KA, Skye SM, Cajka T, Mohan ML, Li L, Wu Y, et al. A cardiovascular disease-linked gut microbial metabolite acts via adrenergic receptors. Cell. 2020;180(5):862–877 e822. doi:10.1016/j.cell.2020.02.016.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Dwidar M, Nemet I, Buffa JA, Sangwan N, Li XS, Anderson JT, Romano KA, Fu X, Funabashi M, et al. Two distinct gut microbial pathways contribute to meta-organismal production of phenylacetylglutamine with links to cardiovascular disease. Cell Host Microbe. 2023;31(1):18–32 e19. doi:10.1016/j.chom.2022.11.015.
   Web of Science ®Google Scholar
• Lu Y, Yang W, Qi Z, Gao R, Tong J, Gao T, Zhang Y, Sun A, Zhang S, Ge J, et al. Gut microbe-derived metabolite indole-3-carboxaldehyde alleviates atherosclerosis. Signal Transduct Target Ther. 2023;8(1):378. doi:10.1038/s41392-023-01613-2.
   Web of Science ®Google Scholar
• Wang Z, Roberts A, Buffa J, Levison B, Zhu W, Org E, Gu X, Huang Y, Zamanian-Daryoush M, Culley M, et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell. 2015;163(7):1585–1595. doi:10.1016/j.cell.2015.11.055.
   PubMed Web of Science ®Google Scholar
• Moludi J, Kafil HS, Qaisar SA, Gholizadeh P, Alizadeh M, Vayghyan HJ. Effect of probiotic supplementation along with calorie restriction on metabolic endotoxemia, and inflammation markers in coronary artery disease patients: a double blind placebo controlled randomized clinical trial. Nutr J. 2021;20(1):47. doi:10.1186/s12937-021-00703-7.
   Web of Science ®Google Scholar
• Malik M, Suboc TM, Tyagi S, Salzman N, Wang J, Ying R, Tanner MJ, Kakarla M, Baker JE, Widlansky ME, et al. Lactobacillus plantarum 299v supplementation improves vascular endothelial function and reduces inflammatory biomarkers in men with stable coronary artery disease. Circ Res. 2018;123(9):1091–1102. doi:10.1161/CIRCRESAHA.118.313565.
   PubMed Web of Science ®Google Scholar
• Sun B, Ma T, Li Y, Yang N, Li B, Zhou X, Guo S, Zhang S, Kwok L-Y, Sun Z, et al. Bifidobacterium lactis probio-M8 adjuvant treatment confers added benefits to patients with coronary artery disease via target modulation of the gut-heart/-brain axes. mSystems. 2022;7(2):e0010022. doi:10.1128/msystems.00100-22.
   Web of Science ®Google Scholar
• Jiang T, Xing X, Zhang L, Liu Z, Zhao J, Liu X. Chitosan oligosaccharides show protective effects in coronary heart disease by improving antioxidant capacity via the increase in intestinal probiotics. Oxid Med Cell Longev. 2019;2019:1–11. doi:10.1155/2019/7658052.
   Web of Science ®Google Scholar
• Sagris M, Vardas EP, Theofilis P, Antonopoulos AS, Oikonomou E, Tousoulis D. Atrial Fibrillation: Pathogenesis, Predisposing Factors, and Genetics. Int J Mol Sci. 2021;23(1):6. doi:10.3390/ijms23010006.
   PubMed Web of Science ®Google Scholar
• Zuo K, Li J, Li K, Hu C, Gao Y, Chen M, Hu R, Liu Y, Chi H, Wang H, et al. Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation. Gigascience. 2019;8(6):giz058. doi:10.1093/gigascience/giz058.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang S, Li B, Luo Y, Gong Y, Jin X, Zhang J, Zhou Y, Zhuo X, Wang Z, et al. Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome. Cardiovasc Res. 2022;118(3):785–797. doi:10.1093/cvr/cvab114.
   PubMed Web of Science ®Google Scholar
• Fang C, Zuo K, Liu Z, Liu Y, Liu L, Wang Y, Yin X, Li J, Liu X, Chen M, et al. Disordered gut microbiota promotes atrial fibrillation by aggravated conduction disturbance and unbalanced linoleic acid/SIRT1 signaling. Biochem Pharmacol. 2023;213:115599. doi:10.1016/j.bcp.2023.115599.
   PubMed Web of Science ®Google Scholar
• Zuo K, Fang C, Liu Z, Fu Y, Liu Y, Liu L, Wang Y, Yin X, Liu X, Li J, et al. Commensal microbe-derived SCFA alleviates atrial fibrillation via GPR43/NLRP3 signaling. Int J Biol Sci. 2022;18(10):4219–4232. doi:10.7150/ijbs.70644.
   PubMed Web of Science ®Google Scholar
• Kong B, Fu H, Xiao Z, Zhou Y, Shuai W, Huang H. Gut microbiota dysbiosis induced by a high-fat diet increases susceptibility to atrial fibrillation. Can J Cardiol. 2022;38(12):1962–1975. doi:10.1016/j.cjca.2022.08.231.
   PubMed Web of Science ®Google Scholar
• Luo Y, Zhang Y, Han X, Yuan Y, Zhou Y, Gao Y, Yu H, Zhang J, Shi Y, Duan Y, et al. Akkermansia muciniphila prevents cold-related atrial fibrillation in rats by modulation of TMAO induced cardiac pyroptosis. EBioMedicine. 2022;82:104087. doi:10.1016/j.ebiom.2022.104087.
   PubMed Web of Science ®Google Scholar
• Orso F, Fabbri G, Maggioni AP. Epidemiology of Heart Failure. Handb Exp Pharmacol. 2017;243:15–33. doi:10.1007/164_2016_74.
   PubMedGoogle Scholar
• Li Z, Wu Z, Yan J, Liu H, Liu Q, Deng Y, Ou C, Chen M. Gut microbe-derived metabolite trimethylamine N-oxide induces cardiac hypertrophy and fibrosis. Lab Invest. 2019;99(3):346–357. doi:10.1038/s41374-018-0091-y.
   PubMed Web of Science ®Google Scholar
• Makrecka-Kuka M, Volska K, Antone U, Vilskersts R, Grinberga S, Bandere D, Liepinsh E, Dambrova M. Trimethylamine N-oxide impairs pyruvate and fatty acid oxidation in cardiac mitochondria. Toxicol Lett. 2017;267:32–38. doi:10.1016/j.toxlet.2016.12.017.
   PubMed Web of Science ®Google Scholar
• Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, Wu Y, Hazen SL. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368(17):1575–1584. doi:10.1056/NEJMoa1109400.
   PubMed Web of Science ®Google Scholar
• Carley AN, Maurya SK, Fasano M, Wang Y, Selzman CH, Drakos SG, Lewandowski ED. Short-chain fatty acids outpace ketone oxidation in the failing heart. Circulation. 2021;143(18):1797–1808. doi:10.1161/CIRCULATIONAHA.120.052671.
   PubMed Web of Science ®Google Scholar
• Romano KA, Nemet I, Prasad Saha P, Haghikia A, Li XS, Mohan ML, Lovano B, Castel L, Witkowski M, Buffa JA, et al. Gut Microbiota-Generated Phenylacetylglutamine and Heart Failure. Circ Heart Fail. 2023;16(1):e009972. doi:10.1161/CIRCHEARTFAILURE.122.009972.
   Web of Science ®Google Scholar
• Zong X, Fan Q, Yang Q, Pan R, Zhuang L, Tao R. Phenylacetylglutamine as a risk factor and prognostic indicator of heart failure. ESC Heart Fail. 2022;9(4):2645–2653. doi:10.1002/ehf2.13989.
   PubMed Web of Science ®Google Scholar
• Wei H, Wu J, Wang H, Huang J, Li C, Zhang Y, Song Y, Zhou Z, Sun Y, Xiao L, et al. Increased circulating phenylacetylglutamine concentration elevates the predictive value of cardiovascular event risk in heart failure patients. J Intern Med. 2023;294(4):515–530. doi:10.1111/joim.13653.
   Web of Science ®Google Scholar
• Hua S, Lv B, Qiu Z, Li Z, Wang Z, Chen Y, Han Y, Tucker KL, Wu H, Jin W, et al. Microbial metabolites in chronic heart failure and its common comorbidities. EMBO Mol Med. 2023;15(6):e16928. doi:10.15252/emmm.202216928.
   Web of Science ®Google Scholar
• Costanza AC, Moscavitch SD, Faria Neto HC, Mesquita ET. Probiotic therapy with saccharomyces boulardii for heart failure patients: a randomized, double-blind, placebo-controlled pilot trial. Int J Cardiol. 2015;179:348–350. doi:10.1016/j.ijcard.2014.11.034.
   PubMed Web of Science ®Google Scholar
• Awoyemi A, Mayerhofer C, Felix AS, Hov JR, Moscavitch SD, Lappegård KT, Hovland A, Halvorsen S, Halvorsen B, Gregersen I, et al. Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial. EBioMedicine. 2021;70:103511. doi:10.1016/j.ebiom.2021.103511.
   Web of Science ®Google Scholar
• Gan XT, Ettinger G, Huang CX, Burton JP, Haist JV, Rajapurohitam V, Sidaway JE, Martin G, Gloor GB, Swann JR, et al. Probiotic administration attenuates myocardial hypertrophy and heart failure after myocardial infarction in the rat. Circ Heart Fail. 2014;7(3):491–499. doi:10.1161/CIRCHEARTFAILURE.113.000978.
   PubMed Web of Science ®Google Scholar
• Karlsson FH, Tremaroli V, Nookaew I, Bergström G, Behre CJ, Fagerberg B, Nielsen J, Bäckhed F. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498(7452):99–103. doi:10.1038/nature12198.
   PubMed Web of Science ®Google Scholar
• Wu IW, Lin C-Y, Chang L-C, Lee C-C, Chiu C-Y, Hsu H-J, Sun C-Y, Chen Y-C, Kuo Y-L, Yang C-W, et al. Gut microbiota as diagnostic tools for mirroring disease progression and circulating nephrotoxin levels in chronic kidney disease: discovery and validation study. Int J Biol Sci. 2020;16(3):420–434. doi:10.7150/ijbs.37421.
   PubMed Web of Science ®Google Scholar
• Cianci R, Franza L, Borriello R, Pagliari D, Gasbarrini A, Gambassi G. The role of gut microbiota in heart failure: when friends become enemies. Biomedicines. 2022;10(11):2712. doi:10.3390/biomedicines10112712.
   Web of Science ®Google Scholar
• Kamo T, Akazawa H, Suda W, Saga-Kamo A, Shimizu Y, Yagi H, Liu Q, Nomura S, Naito AT, Takeda N, et al. Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure. PloS One. 2017;12(3):e0174099. doi:10.1371/journal.pone.0174099.
   PubMed Web of Science ®Google Scholar
• Secombe KR, Al-Qadami GH, Subramaniam CB, Bowen JM, Scott J, Van Sebille YZA, Snelson M, Cowan C, Clarke G, Gheorghe CE, et al. Guidelines for reporting on animal fecal transplantation (GRAFT) studies: recommendations from a systematic review of murine transplantation protocols. Gut Microbes. 2021;13(1):1979878. doi:10.1080/19490976.2021.1979878.
   PubMed Web of Science ®Google Scholar
• Deng K, Xu J-J, Shen L, Zhao H, Gou W, Xu F, Fu Y, Jiang Z, Shuai M, Li B-Y, et al. Comparison of fecal and blood metabolome reveals inconsistent associations of the gut microbiota with cardiometabolic diseases. Nat Commun. 2023;14(1):571. doi:10.1038/s41467-023-36256-y.
   PubMed Web of Science ®Google Scholar
• Wang K, Zhang Z, Hang J, Liu J, Guo F, Ding Y, Li M, Nie Q, Lin J, Zhuo Y, et al. Microbial-host-isozyme analyses reveal microbial DPP4 as a potential antidiabetic target. Science. 2023;381(6657):eadd5787. doi:10.1126/science.add5787.
   Web of Science ®Google Scholar
• Gou W, Ling C-W, He Y, Jiang Z, Fu Y, Xu F, Miao Z, Sun T-Y, Lin J-S, Zhu H-L, et al. Interpretable machine learning framework reveals robust gut microbiome features associated with type 2 diabetes. Diabetes Care. 2021;44(2):358–366. doi:10.2337/dc20-1536.
   PubMed Web of Science ®Google Scholar
• Aryal S, Alimadadi A, Manandhar I, Joe B, Cheng X. Machine learning strategy for gut microbiome-based diagnostic screening of cardiovascular disease. Hypertension. 2020;76(5):1555–1562. doi:10.1161/HYPERTENSIONAHA.120.15885.
   PubMed Web of Science ®Google Scholar
• Korpela K, Salonen A, Vepsäläinen O, Suomalainen M, Kolmeder C, Varjosalo M, Miettinen S, Kukkonen K, Savilahti E, Kuitunen M, et al. Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants. Microbiome. 2018;6(1):182. doi:10.1186/s40168-018-0567-4.
   PubMed Web of Science ®Google Scholar
• Hurkala J, Lauterbach R, Radziszewska R, Strus M, Heczko P. Effect of a short-time probiotic supplementation on the abundance of the main constituents of the gut microbiota of term newborns delivered by cesarean section—A randomized, prospective, controlled clinical trial. Nutrients. 2020;12(10):3128. doi:10.3390/nu12103128.
   PubMed Web of Science ®Google Scholar
• He L, Chen R, Zhang B, Zhang S, Khan BA, Zhu D, Wu Z, Xiao C, Chen B, Chen F, et al. Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes mellitus. Front Immunol. 2022;13:930872. doi:10.3389/fimmu.2022.930872.
   PubMed Web of Science ®Google Scholar
• Nanji AA, Khettry U, Sadrzadeh SM. Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Proc Soc Exp Biol Med. 1994;205(3):243–247. doi:10.3181/00379727-205-43703.
   PubMed Web of Science ®Google Scholar
• Singh S, Sharma RK, Malhotra S, Pothuraju R, Shandilya UK. Lactobacillus rhamnosus NCDC17 ameliorates type-2 diabetes by improving gut function, oxidative stress and inflammation in high-fat-diet fed and streptozotocintreated rats. Benef Microbes. 2017;8(2):243–255. doi:10.3920/BM2016.0090.
   PubMed Web of Science ®Google Scholar
• Dang F, Jiang Y, Pan R, Zhou Y, Wu S, Wang R, Zhuang K, Zhang W, Li T, Man C, et al. Administration of lactobacillus paracasei ameliorates type 2 diabetes in mice. Food Funct. 2018;9(7):3630–3639. doi:10.1039/C8FO00081F.
   PubMed Web of Science ®Google Scholar
• Nakabayashi I, Nakamura M, Kawakami K, Ohta T, Kato I, Uchida K, Yoshida M. Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study. Nephrol Dial Transplant. 2011;26(3):1094–1098. doi:10.1093/ndt/gfq624.
   PubMed Web of Science ®Google Scholar
• Wang IK, Wu Y-Y, Yang Y-F, Ting I-W, Lin C-C, Yen T-H, Chen J-H, Wang C-H, Huang C-C, Lin H-C, et al. The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial. Benef Microbes. 2015;6(4):423–430. doi:10.3920/BM2014.0088.
   PubMed Web of Science ®Google Scholar
• Oliveira RA, Pamer EG. Assembling symbiotic bacterial species into live therapeutic consortia that reconstitute microbiome functions. Cell Host Microbe. 2023;31(4):472–484. doi:10.1016/j.chom.2023.03.002.
   PubMed Web of Science ®Google Scholar
• Estruch R, Lamuela-Raventos RM. Cardiovascular benefits of fermented foods and beverages: still up for debate. Nat Rev Cardiol. 2023;20(12):789–790. doi:10.1038/s41569-023-00938-3.
   Web of Science ®Google Scholar